Univar Announces Distribution Agreement with Swati Spentose for Lidocaine Products
October 22, 2013
REDMOND, Wash. – October 22, 2013 –
Univar Inc., a leading global chemical distributor, announced today that it has entered into an agreement with Swati Spentose Pvt. Ltd. to become its exclusive distributor of lidocaine products, including Lidocaine Base and Lidocaine HCl in the United States. Univar is announcing the partnership at CPhl Worldwide Oct. 22 – 24 in Frankfurt, Germany, where it will be showcasing its pharmaceutical portfolio and technical expertise.
The agreement with Swati Spentose Pvt. Ltd. includes distribution in the United States and Puerto Rico for both Lidocaine Base and Lidocaine HCl. The products are used in a variety of anaesthetic and antiarrhythmic applications in the form of topical, oral, transdermal and injectable products.
“We are very excited to begin this relationship with Swati Spentose,” said Tom Nist, Univar USA Director of Pharmaceutical Ingredients. “The combined manufacturing expertise from Swati Spentose and Univar’s marketing and sales capabilities offers customers greater access to these active pharmaceutical ingredients (API). The Lidocaine Base and Lidocaine HCl are excellent additions to Univar’s API portfolio.”
Univar’s offering to pharmaceutical manufacturers extends beyond traditional technical and formulation support. It includes detailed insight into the industry’s market trends and complex regulatory demands, including stringent quality control and services such as change control management.
“As part of our ongoing commitment to world class manufacturing, we are focused on partnering with companies across the value chain to provide the most comprehensive service to our customers,” said Swati Jajodia, CEO, Swati Spentose Pvt. Ltd. “Univar’s extensive distribution network and commitment to safety, makes it an excellent partner to help us reach more customers with our lidocaine products.”
Univar is one of the world’s leading distributors of industrial and specialty chemicals. Univar represents over 3,500 chemical producers and provides its customer base, made up of 115,000 customers, with a full portfolio of products. Univar operates a global network of more than 260 facilities in North America, Europe, the Asia-Pacific region, and Latin America, with additional sales offices located in Eastern Europe, the Middle East, and Africa. In 2011, Univar reported sales of $9.7 billion. For more information, visit:
Follow Univar on
About Swati Spentose Pvt. Ltd.
Swati Spentose Pvt. Ltd. India has been in the pharmaceutical business for over 43 years, with a multipurpose block, manufacturing three key ingredients: Lidocaine, Meloxicam and Melatonin. With its specialization in polysaccharides like Pentosan Polysulfate Sodium and Dextran, Swati is leading the progress in the field of polysaccharides globally on various scientific dimensions, collaborating with global scientists and institutes. The company has been deeply involved in manufacturing world class quality for Active Pharmaceutical Ingredients (API), bringing new healthcare solutions to the market and providing ingredients for high quality medicines. They have been manufacturing and selling Lidocaine for over 33 years in more than 60 countries worldwide. Swati is currently the largest lidocaine manufacturer and exporter from a single site in the world with capacity of 360 mt / annum; and has made groundbreaking contributions to urology, diabetes related kidney and bone disease, and pain management.For more information, visit:
Press Release: Univar Inc.
Talk to an Expert
send us a question
About Press Releases
Find ChemPoint and related Univar press releases from 2000. Page through the full list of news items at the bottom of the page to view all past press releases.
DECEMBER 2016 (0)
NOVEMBER 2016 (0)
OCTOBER 2016 (0)
AUGUST 2016 (0)
JULY 2016 (0)
JUNE 2016 (0)
MAY 2016 (0)
APRIL 2016 (0)